IP Library Granted Patent US 11,123,130
Granted Patent B2
US 11,123,130 · App. 14/775,247 · Granted Sep 21, 2021

RF tissue ablation devices and methods of using the same

Inventors: James Longoria (Sacramento, CA); Roy Chin (Pleasanton, CA)
Assignee: Charles Somers Living Trust
A61B18/1445A61B18/1402A61B18/1482A61B90/03A61B2018/00059A61B2018/00178A61B2018/00351A61B2018/00363A61B2018/00577A61B2018/00654A61B2018/124A61B2018/145A61B2018/1467A61B2090/032
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,130
App. No.
14/775,247
Granted
Sep 21, 2021
Kind
B2
Abstract

RF tissue ablation devices are provided. Aspects of the RF tissue ablation devices include an elongated member having a proximal and distal end, first and second jaws at the distal end, wherein the first and second jaws are configured to apply intra and inter RF energy to tissue disposed between the jaws during use, and a connector at the proximal end for operatively connecting to a RF energy source. Also provided are systems that include an RF tissue ablation device operatively coupled to a RF energy source, as well as kits that include the devices and methods of using the devices in RF tissue ablation applications, including cardiac applications.

Claims (21)

1. A tissue ablation device, the device comprising:

an elongated member having a proximal and distal end;

first and second jaws at or near the distal end, with at least one of the first and second jaws being collapsible into the elongated member, wherein the first and second jaws are configured to apply intra and inter ablation energy to tissue disposed between the jaws during use, with the first jaw having a central elongated electrode comprising a plurality of positive temperature co-efficient of resistivity (PTCR) material ablation elements connected in series wherein said plurality is flanked by two non-PTCR material electrodes, and with the second jaw having a central elongated electrode comprising a second plurality of PTCR material ablation elements connected in series wherein said second plurality is flanked by two additional non-PTCR material electrodes; and

a connector at the proximal end for operatively connecting to an ablation energy source.

2. The tissue ablation device according to claim 1 , wherein one or more of the PTCR material ablation elements comprises a semiconducting titanate ceramic.

3. The tissue ablation device according to claim 1 , wherein the first and second jaws are configured to not exceed a predetermined compressive force limit on tissue positioned between the jaws during use.

4. The tissue ablation device according to claim 1 , wherein the first and second jaws are configured to assume a parallel configuration prior to clamping tissue.

5. The tissue ablation device according to claim 1 , wherein at least one of the first and second jaws comprises an illumination element.

6. A method of ablating tissue, the method comprising:

positioning the tissue between first and second jaws of a tissue ablation device according to claim 1 , wherein the tissue ablation device is operatively coupled to an ablation energy source; and

applying intra and inter ablation energy to the tissue disposed between the first and second jaws to ablate the tissue.

7. The method according to claim 6 , wherein the tissue is part of a living animal.

8. The method according to claim 7 , wherein the tissue is cardiac tissue.

9. The method according to claim 6 , wherein the method is an open surgical procedure.

10. The method according to claim 6 , wherein the method is a minimally invasive surgical procedure.

11. The method according to claim 6 , wherein at least one of the first and second jaws comprises an illumination element and the method further comprises detecting light from the illumination element with a detector.

12. A kit comprising: a tissue ablation device according to claim 1 ; and sterile packaging, wherein the tissue ablation device is present in the sterile packaging.

13. A system for ablating cardiac tissue, comprising:

a tissue ablation device with an elongated member having a proximal and distal end;

first and second jaws at or near the distal end, with at least one of the first and second jaws being collapsible into the elongated member, wherein the first and second jaws are configured to apply intra and inter ablation energy to tissue disposed between the jaws during use, with the first jaw having a central elongated electrode comprising a plurality of positive temperature co-efficient of resistivity (PTCR) material ablation elements connected in series element that wherein said plurality is flanked by two non-PTCR material electrodes, and with the second jaw having a central elongated electrode comprising a second plurality of PTCR material ablation elements connected in series wherein said second plurality is flanked by two additional non-PTCR material electrodes; and

a connector at the proximal end for operatively connecting to an ablation energy source.

Assignments (4)
SECURITY INTEREST Recorded Jan 10, 2024
From: ATRICURE, INC.; ATRICURE, LLC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066267/0896 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2021
From: CHARLES SOMERS LIVING TRUST
To: ATRICURE, INC.
Reel/Frame 057560/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2020
From: LC THERAPEUTICS, INC.
To: CHARLES SOMERS LIVING TRUST
Reel/Frame 052826/0871 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2015
From: LONGORIA, JAMES; CHIN, ROY
To: LC THERAPEUTICS, INC.
Reel/Frame 036600/0132 →
Continuity (2)
Provisional Application 61800534 · Mar 15, 2013
Related Publication 20160015448A1 · Jan 21, 2016